China's Top Medical Device Maker Says Beijing's Health Reforms Boosted Earnings, But U.S. Outlook Still Uncertain
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The leadership at China's top medical device developer, Mindray Medical International, said this week that the launch of Beijing's health system reforms and massive hospital building program had helped boost profits in the second quarter despite a spending freeze imposed by some medical centers in Mindray's second-largest market, in the U.S